医脉通发布中期业绩 股东应占溢利1.55亿元 同比增加5.9%

Group 1 - The company, 医脉通 (02192), reported revenue of 312 million RMB for the six months ending June 30, 2025, representing a year-on-year increase of 28.2% [1] - The profit attributable to the owners of the parent company was 155 million RMB, reflecting a year-on-year increase of 5.9% [1] - The basic earnings per share were 21.2 cents [1]